LINC02206

Across TCGA pan-cancer cohorts, LINC02206 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated LINC02206 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LINC02206 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC02206 expression acts as an unfavorable survival marker, although some lineages such as BLCA and HNSC show a favorable association.

BLCA, HNSC, and CHOL are the cancer types where LINC02206 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Median	II,III,IV	0.436	0.280	.014	47	view →
HNSC	DFS	Quartile	II,III,IV	0.573	0.306	.002	42	view →
CHOL	OS	Tertile	IV	0.024	0.732	.014	18	view →
COAD	DFS	Tertile	III,IV	0.812	0.631	.027	15	view →
LUSC	DFS	Quartile	III,IV	0.698	0.300	.019	15	view →
BRCA	OS	Tertile	II,III,IV	0.708	0.538	.014	14	view →
LGG	DFS	Tertile	All	0.300	0.430	.010	12	view →
ESCA	OS	Median	III,IV	0.539	0.337	.019	11	view →
OV	OS	Quartile	IV	0.558	0.797	.003	10	view →
CESC	OS	Quartile	All	0.671	0.504	.037	10	view →
MESO	OS	Tertile	IV	0.268	0.652	.023	9	view →
LIHC	DFS	Tertile	III,IV	0.199	0.516	.003	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

LINC02206–BLCA (DFS)

Open the BLCA breakdown →